Myers JW - Search Results

1

A phase II study of pemetrexed in patients with advanced hepatocellular carcinoma.

Cohn AL, Myers JW, Mamus S, Deur C, Nicol S, Hood K, Khan MM, Ilegbodu D, Asmar L. Cohn AL, et al. Among authors: myers jw. Invest New Drugs. 2008 Aug;26(4):381-6. doi: 10.1007/s10637-008-9124-5. Epub 2008 Feb 28. Invest New Drugs. 2008. PMID: 18305899 Clinical Trial.

2

Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck.

Tsao AS, Garden AS, Kies MS, Morrison W, Feng L, Lee JJ, Khuri F, Zinner R, Myers J, Papadimitrakopoulou V, Lewin J, Clayman GL, Ang KK, Glisson BS. Tsao AS, et al. J Clin Oncol. 2006 Sep 1;24(25):4163-9. doi: 10.1200/JCO.2006.05.7851. J Clin Oncol. 2006. PMID: 16943532 Clinical Trial.

3

High-dose cisplatin for locally advanced or metastatic head and neck cancer. A phase II pilot study.

Havlin KA, Kuhn JG, Myers JW, Ozols RF, Mattox DE, Clark GM, von Hoff DD. Havlin KA, et al. Among authors: myers jw. Cancer. 1989 Feb 1;63(3):423-7. doi: 10.1002/1097-0142(19890201)63:3<423::aid-cncr2820630304>3.0.co;2-c. Cancer. 1989. PMID: 2912521

4

Anaphylactoid reactions associated with bisantrene infusions.

Myers JW, Von Hoff DD, Kuhn JG, Osborne CK, Sandbach JF, Pocelinko R. Myers JW, et al. Invest New Drugs. 1983;1(1):85-8. doi: 10.1007/BF00180195. Invest New Drugs. 1983. PMID: 6678858

5

Characterization of the pharmacokinetics of bisantrene (NSC-337766).

Kuhn JG, Ludden TM, Myers JW, Von Hoff DD. Kuhn JG, et al. Among authors: myers jw. Invest New Drugs. 1983;1(3):253-7. doi: 10.1007/BF00208899. Invest New Drugs. 1983. PMID: 6678875

6

Phase I-II trial of methyl-GAG in advanced colon cancer. a Southwest Oncology Group pilot study.

Myers JW, Knight WA 3rd, Livingston RB, Fabian C, Costanzi J. Myers JW, et al. Cancer Clin Trials. 1981 Fall;4(3):277-9. Cancer Clin Trials. 1981. PMID: 7285275

7

Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone] dihydrochloride (CL216,942).

Von Hoff DD, Myers JW, Kuhn J, Sandbach JF, Pocelinko R, Clark G, Coltman CA Jr. Von Hoff DD, et al. Among authors: myers jw. Cancer Res. 1981 Aug;41(8):3118-21. Cancer Res. 1981. PMID: 6265075

8

Phase II clinical trial with bisantrene in patients with advanced refractory small cell lung cancer.

Myers JW, Von Hoff DD, Clark GM, Coltman CA Jr. Myers JW, et al. Cancer Treat Rep. 1984 Jun;68(6):927-8. Cancer Treat Rep. 1984. PMID: 6329511 No abstract available.

9

Combination chemotherapy with cisplatin, bleomycin, and methotrexate in patients with advanced head and neck cancer.

Von Hoff DD, Alberts DS, Mattox DE, Coulthard S, Dana B, Manning M, Myers JW, Griffin CB. Von Hoff DD, et al. Among authors: myers jw. Cancer Clin Trials. 1981;4(2):215-8. Cancer Clin Trials. 1981. PMID: 6166408

10

Systemic inhibition of de novo purine biosynthesis prevents weight gain and improves metabolic health by increasing thermogenesis and decreasing food intake.

Myers JW, Park WY, Eddie AM, Shinde AB, Prasad P, Murphy AC, Leonard MZ, Pinette JA, Rampy JJ, Montufar C, Shaikh Z, Hickman TT, Reynolds GN, Winn NC, Lantier L, Peck SH, Coate KC, Stein RW, Carrasco N, Calipari ES, McReynolds MR, Zaganjor E. Myers JW, et al. bioRxiv [Preprint]. 2024 Nov 1:2024.10.28.620705. doi: 10.1101/2024.10.28.620705. bioRxiv. 2024. PMID: 39553975 Free PMC article. Preprint.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters